Stevanato Group, through Ompi, its specialist in glass primary packaging for the pharmaceutical industry, and SiO2 Medical Products, Inc. (“SMP”) have entered a collaboration agreement.

The agreement will enable pharmaceutical and biologics customers, contract filling organizations, and research laboratories to receive SMP’s proprietary primary containers in Ompi’s industry-recognized EZ-fill packaging configurations in trays and nest & tubs.

SiO2 Medical Products, Inc., a privately-owned company, develops and manufactures precision-molded containers composed of engineered polymers, such as cyclic olefin polymer (COP), and incorporates a thin, transparent, silicon-based coating system composed of organosiloxane and silica nano-layers, which can also incorporate distinct surface properties. This new and patented coating system provides the durability and dimensional consistency of plastics with the oxygen barrier properties, ultra-low extractables, and pH stability of silica glass (i.e., quartz). 

SMP’s primary containers supplied in Ompi’s industry-known packaging configurations readily integrate with existing fill-finish processing lines and accelerate the commercialization of pharmaceuticals and biologics. EZ-fill trays and nest & tubs are designed to mitigate the risk of breakages, cosmetic issues, and particulate generation. Validated to be shipped in quantities as low as a single carton, Ompi EZ-fill offers a solution that can be extended from the clinical trial stage through to industrialization.

Andrea Zambon, marketing director – Pharmaceutical Systems Division, Stevanato Group, said, “With the agreement with SMP, Ompi further strengthens its EZ-fill® technology leadership and market positioning in secondary packaging. Thanks to our flexible, easy to use, and lean solution, clients can immediately integrate the EZ-fill packaging into their fill-finish lines to commercialize their therapies in the primary container of their choice, now including SMP’s proprietary primary containers.”